Eileen M Martin1, Raul Gonzalez2, Jasmin Vassileva3, Antoine Bechara4. 1. Department of Psychiatry, Rush University Medical Center, Chicago, Illinois. 2. Department of Psychology, Florida International University, Miami, Florida. 3. Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia. 4. Department of Psychology, University of Southern California, Los Angeles, California, USA.
Abstract
OBJECTIVE: Substance use is common among individuals infected with HIV, yet whether neurocognitive effects of HIV can be distinguished from more nonspecific effects of drug dependence and associated comorbidities is not known. DESIGN: Cross-sectional observational study of neurocognitive function among HIV-infected and uninfected individuals with and without substance use disorders (SUDs). METHODS: We compared the performance of 458 (31% HIV-infected) substance-dependent individuals (SDIs) and 90 individuals (23% HIV-infected) with no history of SUDs on measures of delay discounting and probability learning, tasks, which are differentially sensitive to addictive processes and HIV serostatus, respectively. RESULTS: In factorial analyses of covariance adjusted for age, years of education, and sex, we found that SDIs showed significantly higher rates of delay discounting, regardless of HIV serostatus (P < 0.05). Conversely, HIV-infected individuals performed significantly more poorly on probability learning compared with uninfected groups, regardless of SUD history (P < 0.05). CONCLUSION: Theory-driven cognitive neuropsychological tasks may have the capacity to detect neurocognitive effects of HIV not attributable solely to substance use; evidence from functional neuroimaging studies with more selective neurocognitive probes will be critical for hypothesis testing and mapping underlying brain systems more precisely.
OBJECTIVE: Substance use is common among individuals infected with HIV, yet whether neurocognitive effects of HIV can be distinguished from more nonspecific effects of drug dependence and associated comorbidities is not known. DESIGN: Cross-sectional observational study of neurocognitive function among HIV-infected and uninfected individuals with and without substance use disorders (SUDs). METHODS: We compared the performance of 458 (31% HIV-infected) substance-dependent individuals (SDIs) and 90 individuals (23% HIV-infected) with no history of SUDs on measures of delay discounting and probability learning, tasks, which are differentially sensitive to addictive processes and HIV serostatus, respectively. RESULTS: In factorial analyses of covariance adjusted for age, years of education, and sex, we found that SDIs showed significantly higher rates of delay discounting, regardless of HIV serostatus (P < 0.05). Conversely, HIV-infected individuals performed significantly more poorly on probability learning compared with uninfected groups, regardless of SUD history (P < 0.05). CONCLUSION: Theory-driven cognitive neuropsychological tasks may have the capacity to detect neurocognitive effects of HIV not attributable solely to substance use; evidence from functional neuroimaging studies with more selective neurocognitive probes will be critical for hypothesis testing and mapping underlying brain systems more precisely.
Authors: Warren K Bickel; Michelle L Miller; Richard Yi; Benjamin P Kowal; Diana M Lindquist; Jeffery A Pitcock Journal: Drug Alcohol Depend Date: 2006-11-13 Impact factor: 4.492
Authors: Scott H Kellogg; Pauline F McHugh; Kathy Bell; James H Schluger; Rosemary P Schluger; K Steven LaForge; Ann Ho; Mary Jeanne Kreek Journal: Drug Alcohol Depend Date: 2003-03-01 Impact factor: 4.492
Authors: Robert H Paul; Kyu Cho; Andrew Belden; Adam W Carrico; Eileen Martin; Jacob Bolzenius; Patrick Luckett; Sarah A Cooley; Julie Mannarino; Jodi M Gilman; Mariah Miano; Beau M Ances Journal: J Neuroimmune Pharmacol Date: 2022-01-04 Impact factor: 4.147
Authors: José Damas; Bruno Ledergerber; Isaure Nadin; Philip E Tarr; Marcel Stoeckle; Ursi Kunze; Christoph Hauser; Klemens Gutbrod; Alexandra Calmy; Frédéric Assal; Patrick Schmid; Thomas Hundsberger; Caroline Di Benedetto; Stefania Rossi; Barbara Hasse; Ladina Schlosser; Renaud Du Pasquier; Katharine E A Darling; Matthias Cavassini Journal: AIDS Date: 2021-12-01 Impact factor: 4.177
Authors: Yunan Xu; Sheri L Towe; Shakiera T Causey; Paul A Dennis; Christina S Meade Journal: Exp Clin Psychopharmacol Date: 2020-08-06 Impact factor: 3.157